We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$22.7B
This Fund
S&P 500
This Quarter
Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$66.6M
(+0.3%)
Cap. Flow
-$1.62B
Cap. Flow
% of AUM
-7.38%
Top 10 Holdings %
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$89.3M |
| 2 |
Keysight
KEYS
|
+$86M |
| 3 |
Nike
NKE
|
+$78.3M |
| 4 |
Amphenol
APH
|
+$76.5M |
| 5 |
Comcast
CMCSA
|
+$72.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$122M |
| 2 |
Celanese
CE
|
+$108M |
| 3 |
Monster Beverage
MNST
|
+$97.8M |
| 4 |
Starbucks
SBUX
|
+$79.7M |
| 5 |
Texas Instruments
TXN
|
+$67.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.94% |
| 2 | Miscellaneous | 15.9% |
| 3 | Financials | 13.57% |
| 4 | Healthcare | 13.29% |
| 5 | Industrials | 9.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.67T
| $529M | 2.41% |
7,201,788
-248,704
| -3% | -$16M |
|
2
Microsoft
MSFT
$3.71T
| $477M | 2.17% |
3,023,299
-61,796
| -2% | -$9.08M |
|
3
Johnson & Johnson
JNJ
$663B
| $271M | 1.24% |
1,857,202
-45,333
| -2% | -$6.15M |
|
4
Accenture
ACN
$114B
| $260M | 1.18% |
1,233,171
-18,181
| -1% | -$3.54M |
|
5
Mastercard
MA
$507B
| $231M | 1.05% |
774,439
+431
| +0.1% | +$122K |
|
|
6
Bristol-Myers Squibb
BMY
$136B
| $224M | 1.02% |
3,487,368
+1,560,071
| +81% | +$89.3M |
|
7
Cisco
CSCO
$431B
| $223M | 1.02% |
4,652,343
-1,301,604
| -22% | -$60.5M |
|
8
Meta Platforms (Facebook)
META
$1.57T
| $221M | 1.01% |
1,078,833
+78,949
| +8% | +$15.3M |
|
9
JPMorgan Chase
JPM
$953B
| $217M | 0.99% |
1,560,263
+1,026
| +0.1% | +$132K |
|
10
Home Depot
HD
$320B
| $208M | 0.95% |
953,197
-121,500
| -11% | -$27.5M |
|
|
11
Comcast
CMCSA
$94B
| $207M | 0.94% |
4,595,593
+1,625,133
| +55% | +$72.3M |
|
12
PayPal
PYPL
$47B
| $203M | 0.93% |
1,879,051
-2,491
| -0.1% | -$260K |
|
13
Omnicom Group
OMC
$22.7B
| $200M | 0.91% |
2,472,557
-81,713
| -3% | -$6.4M |
|
14
Alphabet (Google) Class A
GOOGL
$4.14T
| $200M | 0.91% |
2,985,200
+250,500
| +9% | +$16.2M |
|
15
Vanguard S&P 500 ETF
VOO
$1.05T
| $199M | 0.91% |
671,839
+5,313
| +0.8% | +$1.5M |
|
16
State Street SPDR S&P 500 ETF Trust
SPY
$814B
| $198M | 0.9% |
614,376
+152,435
| +33% | +$46.9M |
|
17
Visa
V
$700B
| $197M | 0.9% |
1,049,965
-13,837
| -1% | -$2.49M |
|
18
Amgen
AMGN
$236B
| $191M | 0.87% |
790,720
-1,661
| -0.2% | -$366K |
|
19
Ametek
AME
$54.5B
| $186M | 0.85% |
1,861,092
-9,353
| -0.5% | -$886K |
|
20
Oracle
ORCL
$457B
| $183M | 0.83% |
3,453,218
+779,164
| +29% | +$42.9M |
|
21
iShares Core S&P Small-Cap ETF
IJR
$110B
| $180M | 0.82% |
2,143,923
+289,766
| +16% | +$23.3M |
|
22
Honeywell
HON
$66.4B
| $174M | 0.79% |
1,043,809
-216,813
| -17% | -$35.4M |
|
23
Merck
MRK
$371B
| $170M | 0.77% |
1,956,833
-213,474
| -10% | -$17.5M |
|
24
Best Buy
BBY
$19B
| $165M | 0.75% |
1,878,159
-37,042
| -2% | -$2.83M |
|
25
Trane Technologies
TT
$98.5B
| $164M | 0.75% |
1,236,643
-125,724
| -9% | -$15.9M |
|
Similar funds
EIM
SOMRS
CB
BBHC
CIG
LF
CI
Glenmede Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 0.3% from $21.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Glenmede Trust withdrew a net $1.62B in Q4 2019, closing 163 positions and reducing 1,007 holdings. Its most notable exit was Celgene Corp, an estimated $122M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, Glenmede Trust opened a new position in Callon Petroleum Company worth $13.8M.
- Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
- Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
- Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
- Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122M.
- Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
- Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
- Glenmede Trust's portfolio value rose 0.3% quarter-over-quarter to $21.9B.
Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.